FPM statement at the commencement of UK’s COVID-19 vaccination programme
Posted on: Tuesday 8 December 2020
Author: FPM
Tuesday 8 December 2020
This morning’s news is uplifting, seeing patients being given the first dose of their vaccination for COVID-19 in clinics up and down the country. It is the culmination of an enormous effort from the scientists and doctors who have developed the vaccine. We must also acknowledge the patients who participated in trials and the companies, regulatory agencies and NHS managers who delivered the research and then ensured the structures were in place to deliver doses to where they are needed. It is a testament to the power of collaboration, innovation, and perseverance.
We hope this is now the beginning of the end of this terrible pandemic. However, given the requirement for two doses of this vaccine to be given and the time needed for efficacy, its effects will not be seen until well into the new year. We therefore urge everyone to remain vigilant and continue to follow the government/NHS guidelines on maintaining hygiene, keeping a safe distance, wearing a mask and limiting contact.
Read our COVID-19 blog articles
It’s All Greek to Me: SARS-CoV-2 Variants, Vaccines and Antivirals
A Deep Dive by Professor Penny Ward et al
Understanding and responding to the impacts of COVID-19 on women’s health
Dr Sheuli Porkess examines the disproportionate impact of the pandemic on women and women’s health
COVID-19 antivirals and vaccine boosters: an update and general considerations
Dr Marianna Lalla discusses the current debates over COVID-19 antivirals and vaccine boosters
FPM Statement on COVID Vaccine Supply May 2021
FPM urges governments, industry and regulators to collaborate to find solutions to ensure supply as soon as soon as possible.
A Year with the ‘First Horseman’
Penny Ward reflects on what we have learned one year after the WHO announced the start of the COVID-19 pandemic.
Inhalation therapies for COVID-19
Can we inhibit the initial stages of the infection of the respiratory tract?
Pregnancy, COVID-19 and Emerging Therapeutic Options
Allyah Abbas-Hanif, Sue Tansey, Sankarasubramanian Rajaram, Penny Ward
The End of the Transition Period and Recent announcements from the MHRA
What do you need to know for 1 January 2021?
FPM Clinical Trials Resilience Survey – Report Published
Adaptations and innovations made to clinical trial programmes and regulatory frameworks during the COVID-19 pandemic.
FPM Contributes to AoMRC Vaccination Letter
To Chris Whitty and the NHSE/I Vaccine Implementation Team
Blog article: Preparedness Planning on Public Health Emergencies (PHEs)
The webinar series that has brought FPM into the heart of the COVID-19 pandemic.
COVID-19 – Characterisation of the paediatric disease and evolving therapeutic options
New blog article from Sankarasubramanian Rajaram, Sue Tansey et al
What you need to know about COVID-19 testing
An article by Robert L Holland FFPM and John Bagshaw of the British In Vitro Diagnostics Association
Press release: Faculty of Pharmaceutical Medicine launches ‘Principles for Clinical Studies into COVID-19’ guidance
Read the press release
COVID-19 – how pharmaceutical medicine is meeting the challenge
A report of the FPM survey of members on the effect of COVID-19 on their professional lives
The ethics of conducting clinical trials in the search for treatments and vaccines against COVID-19
Some of the important ethical issues when planning and conducting clinical trials in the COVID 19 pandemic.
COVID-19/SARS-CoV-2 Pandemic
A landmark review by Dr Penny Ward et al addressing current knowledge concerning SARS-CoV-2 and COVID-19 disease.
COVID-19 – how to make yourself available to the NHS
Instructions on how to make yourself available for clinical work
